View in EDS HTML Full Text PDF Full Text

Targeting heptad repeats and fusion peptide: nanoparticle vaccine elicits mucosal immune response against SARS-CoV-2 variants.

Saved in:
Bibliographic Details
Title: Targeting heptad repeats and fusion peptide: nanoparticle vaccine elicits mucosal immune response against SARS-CoV-2 variants.
Authors: Liang, Chaofeng1,2,3 (AUTHOR), Li, Rong3,4 (AUTHOR), Pu, Zeyu3 (AUTHOR), Chen, Ran3 (AUTHOR), Li, Yuzhuang3 (AUTHOR), Chen, Siqi3 (AUTHOR), Feng, Jinzhu3 (AUTHOR), Liu, Jie3 (AUTHOR), Bai, Yuteng3 (AUTHOR), Qin, Xuewen3 (AUTHOR), Xie, Chengjie3 (AUTHOR), Zhang, Yixin3 (AUTHOR), Peng, Yi3 (AUTHOR), Tang, Hui3 (AUTHOR), Zhang, Mei3 (AUTHOR), Zhang, Qiuyue5 (AUTHOR), Wang, Tao3 (AUTHOR), Li, Baisheng4 (AUTHOR), Zhang, Huan4 (AUTHOR), Zhang, Xu3 (AUTHOR)
Source: Journal of Nanobiotechnology. 7/3/2025, Vol. 23 Issue 1, p1-15. 15p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14773155
DOI:10.1186/s12951-025-03582-w